Published in Gut on June 01, 2002
Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer | NCT02343614
WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA (2016) 2.68
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
Can we safely target the WNT pathway? Nat Rev Drug Discov (2014) 2.31
Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci (2011) 1.84
Current ideas in desmoid tumours. Fam Cancer (2006) 1.82
Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut (2002) 1.81
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila) (2011) 1.70
P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J (2002) 1.48
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta (2008) 1.36
Dual roles for immunity in gastrointestinal cancers. J Clin Oncol (2010) 1.31
Endoscopic management of nonampullary duodenal polyps. Therap Adv Gastroenterol (2012) 1.28
Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol (2011) 1.17
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest (2009) 1.14
Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol (2006) 1.13
Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol (2012) 1.11
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer (2006) 1.11
Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut (2005) 1.09
Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch (2004) 1.07
Inherited colorectal cancer syndromes. Cancer J (2011) 1.06
Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol (2007) 1.03
Familial adenomatous polyposis: The practical applications of clinical and molecular screening. Fam Cancer (2006) 1.02
Diagnosis and management of ampullary adenoma: The expanding role of endoscopy. World J Gastrointest Endosc (2011) 0.98
Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol (2004) 0.97
Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins. Mol Cancer Res (2010) 0.97
Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage. Proc Natl Acad Sci U S A (2004) 0.92
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer (2003) 0.90
The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet (2015) 0.89
Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford) (2011) 0.89
Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis. Curr Treat Options Gastroenterol (2004) 0.88
Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling. Mol Cancer (2013) 0.87
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun (2015) 0.87
A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2. Cancer Lett (2009) 0.87
Intussusception in the adult: an unsuspected case of Peutz-Jeghers syndrome with review of the literature. Fam Cancer (2008) 0.87
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
Surveillance in Lynch syndrome. Fam Cancer (2005) 0.85
Surgical treatment in familial adenomatous polyposis. Ann Gastroenterol (2012) 0.83
Risk of duodenal cancer in patients with familial adenomatous polyposis. Gut (2004) 0.82
RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. J Biomed Biotechnol (2010) 0.81
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol (2013) 0.81
Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas. Vaccine (2007) 0.81
Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma. Br J Ophthalmol (2005) 0.81
The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development. Res Rep Biochem (2014) 0.80
The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials. Front Oncol (2014) 0.80
Chemoprevention with special reference to inherited colorectal cancer. Fam Cancer (2007) 0.80
Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP. Fam Cancer (2010) 0.80
Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair. Neuropharmacology (2013) 0.80
Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol (2016) 0.80
Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis. Int J Colorectal Dis (2009) 0.79
Non-steroidal anti-inflammatory drugs and colorectal cancer prevention. Postgrad Med J (2005) 0.79
Potential use of COX-2-aromatase inhibitor combinations in breast cancer. Br J Cancer (2005) 0.79
Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation. Int J Inflam (2010) 0.79
Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med (2016) 0.78
The current status of chemoprevention in FAP. Fam Cancer (2006) 0.78
Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. Br J Cancer (2010) 0.78
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2. Oncotarget (2016) 0.78
Emerging strategies for cancer immunoprevention. Oncogene (2015) 0.77
Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study. Ther Adv Urol (2015) 0.77
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial. Orphanet J Rare Dis (2013) 0.77
Duodenal adenoma surveillance in patients with familial adenomatous polyposis. World J Gastrointest Endosc (2015) 0.77
Novel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases. Curr Colorectal Cancer Rep (2012) 0.77
Microenvironment-a role in tumour progression and prognosis. J Clin Diagn Res (2013) 0.77
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls. Orphanet J Rare Dis (2013) 0.76
Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective. ISRN Oncol (2011) 0.76
In the beginning there was colectomy: current surgical options in familial adenomatous polyposis. Hered Cancer Clin Pract (2004) 0.76
Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.76
Chemoprevention of colorectal cancer. Dig Dis (2014) 0.76
Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy? Fam Cancer (2012) 0.76
Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract. Pharmaceuticals (Basel) (2010) 0.75
Duodenal adenoma and cancer in FAP. Gut (2005) 0.75
Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Mouse models of inherited cancer syndromes. Hematol Oncol Clin North Am (2010) 0.75
11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis. J Oncobiomarkers (2013) 0.75
Chemoprevention of familial adenomatous polyposis. Fam Cancer (2016) 0.75
An unusual case of familial adenomatous polyposis with very early symptom occurrence. Fam Cancer (2014) 0.75
Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. Fam Cancer (2016) 0.75
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 8.60
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell (1996) 7.46
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet (1989) 3.84
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res (1998) 3.11
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg (1993) 2.70
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg (1993) 1.32
Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol (1994) 1.29
Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl (1996) 1.25
Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet (1995) 1.25
Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol (1999) 1.12
Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg (1998) 1.05
Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol Suppl (1997) 0.99
Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J Surg (1996) 0.96
Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg (1996) 0.85
Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? J Rheumatol Suppl (1999) 0.84
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev (1999) 13.43
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature (1993) 4.87
A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. JAMA (1996) 4.80
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41
Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol (1995) 4.22
Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry (2001) 4.13
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet (2009) 3.99
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87
Tracing the stepwise oxygenation of the Proterozoic ocean. Nature (2008) 3.85
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet (2000) 3.25
Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene (2006) 3.10
Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg (1992) 2.98
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut (2004) 2.92
Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health (2003) 2.90
American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin (1997) 2.89
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol (2004) 2.83
Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology (1981) 2.75
Surveillance guidelines after removal of colorectal adenomatous polyps. Gut (2002) 2.71
Localization of avian tumor virus group-specific antigen in cell and virus. Virology (1966) 2.70
Allelic variation at the VRN-1 promoter region in polyploid wheat. Theor Appl Genet (2004) 2.61
Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child (1967) 2.56
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res (1995) 2.56
The group-specific antigen and other structural proteins of hamster and mouse C-type viruses. Virology (1971) 2.46
White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology (2006) 2.42
A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy (2008) 2.40
DSPP mutation in dentinogenesis imperfecta Shields type II. Nat Genet (2001) 2.39
Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction (1997) 2.33
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys (1999) 2.29
A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short- and long-term results of a randomized clinical trial. AIDS Care (2002) 2.28
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther (1994) 2.27
Metachronous carcinoma of the large intestine and intestinal polyps. Proc R Soc Med (1967) 2.26
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res (2000) 2.21
Post-earthquake quality of life and psychological well-being: longitudinal evaluation in a rural community sample in northern China. Psychiatry Clin Neurosci (2000) 2.20
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination. Genome Res (1997) 2.17
Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron (1999) 2.16
Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA (2001) 2.16
Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet (1994) 2.13
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Effect of crossover on the statistical power of randomized studies. Ann Thorac Surg (1989) 2.09
Configurational diffusion down a folding funnel describes the dynamics of DNA hairpins. Proc Natl Acad Sci U S A (2001) 2.08
Changes in the helical repeat of poly(dG-m5dC) . poly(dG-m5dC) and poly(dG-dC) . poly(dG-dC) associated with the B-Z transition. Nature (1981) 2.06
A new variable stiffness colonoscope makes colonoscopy easier: a randomised controlled trial. Gut (2000) 2.06
Characterization of 16S rRNA genes from oil field microbial communities indicates the presence of a variety of sulfate-reducing, fermentative, and sulfide-oxidizing bacteria. Appl Environ Microbiol (1996) 2.05
The continuous diaphragm sign. A newly-recognized sign of pneumomediastinum. Clin Radiol (1973) 2.05
Simultaneous shotgun sequencing of multiple cDNA clones. DNA Seq (1997) 2.04
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys (1995) 2.03
Improving care for minority children with asthma: professional education in public health clinics. Pediatrics (1997) 2.02
Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics (1992) 2.00
Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal. Am J Public Health (1996) 2.00
Antirotation proximal femoral nail versus dynamic hip screw for intertrochanteric fractures: a meta-analysis of randomized controlled studies. Orthop Traumatol Surg Res (2013) 1.97
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res (2000) 1.96
601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg (1999) 1.96
Infectious causes of equine respiratory disease on Ontario standardbred racetracks. J Clin Microbiol (1977) 1.95
Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet (1996) 1.93
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
Regulatory mechanisms of cellular response to oxidative stress. Free Radic Res (1999) 1.92
Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology (1994) 1.91
Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut (2007) 1.90
The impact of passive smoking on emergency room visits of urban children with asthma. Am Rev Respir Dis (1987) 1.89
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res (2000) 1.88
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol (1995) 1.86
A school health education program for children with asthma aged 8-11 years. Health Educ Q (1987) 1.85
A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol (2000) 1.82
Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut (2002) 1.81
Crystallographic findings on the internally uncoupled and near-rigor states of myosin: further insights into the mechanics of the motor. Proc Natl Acad Sci U S A (2002) 1.81
Maternal smoking and trisomy among spontaneously aborted conceptions. Am J Hum Genet (1983) 1.80
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene (2008) 1.79
Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg (2000) 1.79
Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders. Mol Psychiatry (2004) 1.79